Table 1 Characteristics of 111 advanced lung adenocarcinoma patients
Characteristic | Total (N = 111) | % |
|---|---|---|
Sex | ||
Male | 40 | 36.04% |
Female | 71 | 63.96% |
Age, n (%) | ||
Median age, y (range)53 | ||
≥ 60 | 32 | 28.83% |
< 60 | 79 | 71.17% |
Tobacco smoking, n (%) | ||
yes | 21 | 18.92% |
no | 90 | 81.08% |
EGFR mutation, n (%) | ||
19 | 49 | 44.14% |
21 | 50 | 45.05% |
other | 12 | 10.81% |
Dose, Gy | ||
< 50 | 25 | 22.52% |
≥ 50, < 60 | 35 | 31.53% |
≥ 60 | 51 | 45.95% |
Number of radiotherapy sites | ||
1 | 28 | 25.23% |
2 | 52 | 46.85% |
3 | 24 | 21.62% |
4 | 3 | 2.70% |
5 | 3 | 2.70% |
6 | 1 | 0.90% |
The Site of Radiotherapy | ||
Thoracic | 111 | 100.00% |
Brain | 60 | 54.05% |
Bone | 47 | 42.34% |
Radiation pneumonitis | ||
G1 | 69 | 62.16% |
G2 | 10 | 9.01% |
G3 | 4 | 3.60% |
Radiotherapy targeting synchronization | ||
yes | 19 | 17.12% |
no | 92 | 82.88% |